Loading organizations...
§ Private Profile · Boston, MA, USA
Technology platform enabling remote patient monitoring and in-home acute and complex care delivery for healthcare systems and pharma.
Current Health is a Boston, Massachusetts-based healthcare technology company that provides a remote patient monitoring platform to enable health systems to deliver acute and complex care in home settings. The enterprise software platform integrates connected medical devices with patient-reported data to coordinate hospital-at-home programs and outpatient therapies. Prior to its initial acquisition by Best Buy for $400 million in 2021, the company had raised over $70 million in venture capital and grown its workforce to more than 150 employees. The organization serves major healthcare providers and pharmaceutical companies, securing strategic partnerships with Atrium Health, Sarah Cannon, and Bristol Myers Squibb. After a four-year ownership period under the retailer, the enterprise was sold back to its original leadership in mid-2025. Current Health was founded in Edinburgh, Scotland, in 2014 by Christopher McGhee and Stewart Whiting.
Current Health has raised $91.1M across 9 funding rounds.
Current Health has raised $91.1M in total across 9 funding rounds.
Current Health is a healthcare technology company that provides an enterprise clinical operating system for delivering high-acuity care safely and scalably in home and community settings.[1][3][5] Its platform combines a proprietary FDA-cleared wearable for continuous vital sign monitoring, third-party devices, telehealth, patient engagement tools, and EHR integrations to support programs like Hospital at Home, advanced therapies (e.g., CAR-T), post-discharge care, and chronic disease management.[2][5][6] The company serves healthcare providers, health systems, and biopharma companies, solving the challenges of shifting complex care from hospitals to lower-cost settings while maintaining clinical quality, reducing provider burden, and improving patient outcomes and financial results.[1][3][7] With 51-200 employees based in California, Current Health has demonstrated growth through partnerships with over 50 health systems worldwide, including major expansions like Mass General Brigham's Home Hospital program serving 70+ patients.[7][8]
Current Health was co-founded by Christopher McGhee, inspired by his grandmother's unnecessary extended hospital stay for a condition that could have been managed at home with proper support.[3] This personal experience sparked the mission to enable hospitals to deliver hospital-level care beyond their walls.[3] The company originated as a remote patient monitoring (RPM) platform and gained early traction through FDA-cleared technology for vital sign monitoring and alarming.[2][6] In 2021, it expanded under the backing of Best Buy Health, a major U.S. technology leader, integrating with programs like Geisinger's ConnectedCare365 for chronic care.[3][4] By 2025, former CEO Christopher McGhee led a buyback, returning the company to independence to refocus on scrappy innovation, patient safety, and customer needs amid evolving AI and care-at-home demands.[3][4][9]
Current Health stands out in the care-at-home space through purpose-built technology and operational support tailored for real-world complexity:
Current Health rides the Hospital at Home and care-at-home trend, accelerated by post-pandemic shifts to reduce inpatient strain, lower costs, and improve outcomes amid workforce shortages and rising chronic disease prevalence.[1][8] Timing is ideal as CMS expansions and payer incentives favor lower-cost, high-margin settings, with Hospital at Home proven to cut complications and boost recovery.[8] Market forces like EHR interoperability mandates and AI advancements enable seamless scaling, positioning Current Health to influence ecosystem-wide adoption by providing turnkey infrastructure that health systems trust for complex care.[3][6][9] Its independence in 2025 allows agile responses to these dynamics, bridging providers and biopharma for therapies like CAR-T in outpatient/home environments.[1][4]
Current Health is poised for accelerated growth as an independent player, emphasizing rapid product innovation, AI-driven automation, and expanded health monitoring services to scale care-at-home cost-efficiently.[9] CEO McGhee's priorities—enhancing clinical teams, leveraging AI for frontline efficiency, and recapturing startup agility—align with a maturing market where AI transforms remote care delivery.[9] Influence may evolve through deeper AI-alarm integrations, broader chronic care ecosystems, and global expansions, solidifying its role in making high-acuity home care standard. This return to roots echoes its origin in personal necessity, now amplified by technology to transform healthcare accessibility.[3][9]
Current Health has raised $91.1M across 9 funding rounds. Most recently, it raised $43.0M Series B in April 2021.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Apr 1, 2021 | $43M Series B | Northpond Ventures | Helium 3 Ventures, MMC Ventures, Platanus Ventures, Presight Capital, Section 32, Valar Ventures, Christian Woolfenden, Matt Bellamy, Richard Fearn, Eros Resmini, Elements Health Ventures, Tripp Peake, Stan Lynall | Announced |
| Jun 1, 2020 | $4M Series A | — | PAR Equity | Announced |
| Dec 1, 2019 | $12M Series A | Bruce Macfarlane | PAR Equity, Chris Knight, Kerry Sharp | Announced |
| Nov 1, 2019 | $12M Series U | — | PAR Equity | Announced |
| Jul 26, 2018 | $8M Seed | Michael Dimelow | Gareth Williams, Gordon Craig, Qasar Younis, David Kelnar | Announced |
| Jul 1, 2018 | $7M Series U | — | PAR Equity | Announced |
| Dec 1, 2017 | $57K Series U | — | PAR Equity | Announced |
| Apr 1, 2017 | $3M Seed | — | PAR Equity | Announced |
| Oct 1, 2016 | $2M Seed | PAR Equity | — | Announced |
Current Health has raised $91.1M in total across 9 funding rounds.
Current Health's investors include Northpond Ventures, Helium-3 Ventures, MMC Ventures, Platanus Ventures, Presight Capital, Section 32, Valar Ventures, Christian Woolfenden, Matt Bellamy, Richard Fearn, Eros Resmini, Elements Health Ventures.